BlackRock Inc. doubles down on AI megacaps and upstream chips in 2024-Q2

The clearest signal this quarter is the explosive repositioning in Nvidia. Shares are up +906.7%, driving an estimated $204.9B increase to $227.5B in value, turning it from a large position into a defining macro bet on GPU scarcity and AI infrastructure spending.

Microsoft, Apple, and Amazon all see incremental adds — $3.5B, $2.9B, and $1.4B of estimated capital, respectively — reinforcing a view that the cloud-and-consumer platforms best placed to capture AI spend should sit at the top of the stack. Meta and Alphabet’s A shares are also nudged higher, rounding out a full-faith commitment to the U.S. hyperscaler and ad-tech oligopoly.

Under the surface, BlackRock is also leaning into the plumbing of the AI buildout, not just the headline chips:

• AMAT (Applied Materials) added +6.1% in shares, about $1.07B more, is a bet on wafer fab equipment as the gating factor in capacity.
• LRCX (Lam Research) and NOW (ServiceNow), both with +5.7% share increases, extend that logic to advanced etch and enterprise workflow automation.
• AMD and QCOM get meaningful boosts (+4.9% and +2.3% in shares), a clear nod that AI at the edge and in PC/handset form factors is a second leg of the cycle.

Outside strict tech, XOM is quietly ramped +10.8% in shares (about $3.4B more), and JNJ rises +4.5% (about $1.2B). That looks like a barbell: AI-heavy growth on one side, super-majors and high-quality pharma as ballast on the other.

If the buys are about AI and scale platforms, the trims tell you what BlackRock thinks can be safely diluted. The biggest single tech cut is AVGO, with shares down -2.0% and about $1.1B taken off the table — not an abandonment, but a recycle from a richly rerated semiconductor winner into Nvidia and the broader chip complex.

In health care, the knife falls on legacy cash cows rather than growth stories. ABBV is cut -4.6% (about -$1.1B), AMGN -4.0% (about -$602.5M), ABT -1.8%, and MRK nudged lower. This looks like a rotation out of mature, patent-cycle–sensitive pipelines to free up capital for JNJ and LLY, and ultimately to feed the tech build.

Financials are a clear funding source. BAC is down -3.0% in shares (roughly -$591.6M), WFC -4.2% (about -$656.3M), and JPM modestly trimmed. The message: traditional rate-sensitive bank earnings are less compelling than owning the companies that set the price of compute.

Smaller trims in CVX (about -$204.0M), ADBE (about -$174.2M), UNH, and even the GOOG share line show a willingness to take gains or shave around winners to keep absolute exposure to the AI core and chip equipment names climbing without blowing out overall risk.

The sector chart shows a blunt reality: tech is no longer just overweight; at 56.21% of this top-50 slice it effectively is the portfolio, up from 51.29% last quarter. That five-point move is funded almost entirely by simultaneous cuts across every other major sector.

Consumer-facing names give ground despite small adds to AMZN, COST, PG, HD, WMT, and NFLX. Aggregate Consumer Discretionary weight falls from 13.15% to 11.86%, indicating those are being kept as durable cash-flow compounds rather than active risk engines.

Health care drops from 11.75% to 10.45% as ABBV, AMGN, ABT, MRK, and ISRG are trimmed or flat, partially offset by JNJ and LLY. Finance shrinks from 4.09% to 3.58% on cuts to BAC and WFC, and even the nominal "Real Estate" bucket (really payments and consulting: V, MA, ACN) edges down from 4.26% to 3.83%.

Energy is roughly stable at 2.65% versus 2.80%, but the mix tilts toward XOM over CVX. Telecommunications, consumer staples, and industrials all drift slightly lower in weight despite tiny adds to names like CSCO, VZ, TMO, and TSLA. The net effect: a benchmark-like shell, but with a deliberate skew that channels more of every marginal dollar into semis and software tied to AI compute cycles.

Taken together, this is BlackRock using its own book to express a view that AI will behave less like a fad and more like the internet in the 1990s: a capex-heavy, winner-take-most transformation anchored in a few platforms and their suppliers. The outsized acceleration into Nvidia and the steady reinforcement of Microsoft, Apple, and Amazon say they expect these names to define index returns rather than merely participate in them.

The supporting cast underscores that view. Additions to AMAT, LRCX, AMD, QCOM, and NOW hint at a belief that the scarcity will migrate from GPUs to tools, capacity, and software integration — and that returns will follow along that chain. Modest increases in XOM, JNJ, KO, and a basket of broad ETFs (IVV, IXUS) suggest they still care about ballast and liquidity, but they are comfortable letting AI-heavy tech dictate the portfolio’s trajectory.

Going forward, watch three fault lines. First, whether they keep pressing semicap (AMAT, LRCX) and edge silicon (AMD, QCOM) as the cycle matures. Second, how far they are willing to keep hollowing out traditional banks and legacy pharma to pay for that. Third, whether top-10 concentration — already 27.3% — creeps higher, which would turn this from an AI-tilted index proxy into a concentrated bet that a handful of compute landlords will continue compounding at the expense of the rest of the market.